Hypermetaphase fluorescence in situ hybridization for quantitative monitoring of Philadelphia chromosome-positive cells in patients with chronic myelogenous leukemia during treatment

Blood

Volumn 86, Issue 6, 1995, Pages 2343-2349

  Seong, David C ^a   Kantarjian, Hagop M ^a   Ro, Jae Y ^a   Talpaz, Moshe ^a   Xu, Jingping ^a   Robinson, Johnnie R ^a   Deisseroth, Albert B ^a   Champlin, Richard E ^a   Siciliano, Michael J ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CYTARABINE; DEMECOLCINE;

ARTICLE; BONE MARROW CELL; CHROMOSOME 9Q; CHROMOSOME ANALYSIS; CHROMOSOME REARRANGEMENT; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CULTURE MEDIUM; DOUBLE BLIND PROCEDURE; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; HUMAN CELL; METAPHASE; MITOSIS INDEX; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL;

EID: 0029098199     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v86.6.2343.bloodjournal8662343     Document Type: Article

References (18)

1. Rowley JD: A new consistent chromosomal abnormality in chronic myelogenous leukemia identified by quinacrine fluorescence and Giemsa staining. Nature 243:290, 1973
2. Trujillo JM, Cork A, Ahearn MJ, Youness EL, McCredie KB: Hematologic and cytologic characterization of 8/21 translocation in acute granulocytic leukemia. Blood 53:695, 1979
3. Liu P, Siciliano J, Seong D, Craig J, Zhao Y, de Jong PJ, Siciliano MJ: Dual Alu PCR primers and conditions for isolation of human chromosome painting probes from hybrid cells. Cancer Genet Cytogenet 65:93, 1993
4. 1-positive chronic myelogenous leukemia (CML) involving chromosomes #1, #9, and #22 by fluorescence in situ hybridization. Cancer Genet Cytogenet 65:100, 1993
5. Talpaz M, Kantarjian HM, Keating MJ, Talpaz M, McCredie KB, Freireich J: Clinical investigation of human alpha interferon in chronic myeloid leukemia. Blood 69:1280, 1987
6. Henske EP, Ozelius L, Anderson MA, Kwiatkowski DJ: A radiation-reduced hybrid cell line containing 5 Mb/17 cM of human DNA from 9q34. Genomics 13:841, 1992
7. Bickel PJ, Dobsum KA: Mathematical Statistics: Basic Ideas and Selected Topics. San Francisco, CA, Holden-Day, 1977
8. The Italian Cooperative Study Group on Chronic Myeloid Leukemia: Interferon alpha-2A as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Engl J Med 330:820, 1994
9. Kantarjian HM, Smith TL, O'Brien S, Beran M, Robertson LE, Koller C, Pierce S, Estey E, Keating M, Talpaz M: Prolonged survival in chronic myelogenous leukemia following cytogenetic response to alpha interferon therapy. Ann Intern Med 122:254, 1995
10. 1 chromosome abnormalities in CML: A report of two unique cases. Blood 63:399, 1984
11. Lee MS, LeMaistre A, Kantarjian H, Talpaz M, Freireich E, Trujillo J, Stass S: Detection of two alternative bcr/abl MRNA junctions and minimal residual disease in Philadelphia chromosome positive chronic myelogenous leukemia by polymerase chain reaction. Blood 73:2165, 1989
12. Tkachuk DC, Westbrook CA, Andreeff M, Donlon TA, Cleary ML, Suryanarayan K, Homge M, Redner A, Gray J, Pinkel D: Detection of bcr-abl fusion in chronic myelogenous leukemia by in situ hybridization. Science 250:559, 1990
13. Bentz M, Cabot G, Moos M, Speicher MR, Ganser A, Lichter P, Dohner H: Detection of chimeric BCR-ABL genes on bone marrow samples and blood smears in chronic myeloid and acute lymphoblastic leukemia by in situ hybridization. Blood 83:1922, 1994
14. Seong DC, Song MY, Henske E, Zimmerman SO, Champlin RE, Deisseroth AB, Siciliano MJ: Analysis of interphase cells for the Philadelphia translocation using painting probe made by interalu PCR from a radiation hybrid. Blood 83:2268, 1994
15. Miller W, Blechert G: Inverse PCR across bcr/abl genomic breakpoint allows sensitive detection of Ph-containing cells. Blood 84:494a, 1994 (suppl 1)
16. Zhang JG, Lin F, Cross NCP, Goldman JM: Detection of residual disease after BMT for CML by amplification of the bcr-abl breakpoint from genomic DNA: Comparison with RT-PCR. Blood 84:496a, 1994 (suppl 1)
17. Kantarjian HM, Deisseroth A, Kurzrock R, Estrov Z, Talpaz M: Chronic myelogenous leukemia: A concise update. Blood 82:691, 1993
18. Majlis A, Kantarjian H, Smith T, Talpaz M, O'Brien S, Keating M, Freireich E: What is the significance of cytogenetic clonal evolution (CE) in patients (PTS) with Philadelphia chromosome (Ph)-positive chromonic myelogenous leukemia (CML)? Blood 84:150a, 1994 (suppl 1)